(
SEVAMED 2003)
(Diagnosis,
Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis,
Vaccines & Drugs)
January 2003
6044.
Melrose WD. Lymphatic filariasis: new insights into an old disease. Int J
Parasitol. 2002 Jul;32(8):947-60. Review.
6045.
Sehri P, Krishnanand G, Gupta A, Mukherjee A. Breast filariasis. Indian J
Path Microbiol. 200; 43(3): 363-4.
Therapy:
6046.
Etya'ale D. Eliminating onchocerciasis as a public health problem: the
beginning of the end. Br J Ophthalmol. 2002 Aug;86(8):844-6.
6047.
Sharma DC. New goals set for filariasis elimination in India. Lancet
Infect Dis. 2002 Jul;2(7):389.
6048. Unnasch TR. River blindness. Lancet. 2002 Jul 20;360(9328):182-3.
April 2003
6672. Arya SC.An enzyme-linked immunosorbent assay (ELISA) format to diagnose Wuchereria bancrofti specific immunoglobulin G4 class in urine samples.Am J Trop Med Hyg 2002 Oct;67(4):335
6673. Birley H, Duerden B, Hart CA, Curless E, Hay PE, Ison CA, Renton AM, Richens J, Wyatt GB.Sexually transmitted diseases: microbiology and management.J Med Microbiol 2002 Oct;51(10):793-807
6674. Bregani ER, Ghiringhelli C, Ceraldi T, Rovellini A. Identification of Mansonella perstans microfilariae in ascitic fluid.Trop Doct 2002 Oct;32(4):249-50
6675. Dash PK; Mishra GC; Pattanaik MR; Mohapatra N; Behera G. Clinical profile of tropical pulmonary eosinophilia with special reference to bronchoalveolar lavage Antiseptic. 2002 Sep; 99(9): 332-4
6676. Kipp W, Bamhuhiiga J. Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda. Am J Trop Med Hyg 2002 Nov;67(5):475-9
6677. Kundu AK, Giri A, Ghosh G, Saha SR.Microfilaria in a thyroid nodule which resolved on treatment. Trop Doct 2002 Oct;32(4):248
6678. R. Alli, B. Bhunia, GP Chhotray, MVR Reddy, BC Harinath. Microscopic haematuria as an occult filarial infection in Bhubaneshwar an endemic area for bancroftian filariasis. Indian J of Clin Biochem 2003, 18 (1): 61-64.
6679. Stringfellow GJ, Francis IC, Coroneo MT, Walker J.Orbital dirofilariasis. Clin Experiment Ophthalmol 2002 Oct;30(5):378-80
6679.Supali T, Ismid IS, Ruckert P, Fischer P. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.Trop Med Int Health 2002 Oct;7(10):894-901
Pathogenesis:
6680. Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW. Mass treatment to eliminate filariasis in Papua New Guinea.N Engl J Med 2002 Dec 5;347(23):1841-8
6681. Cooper PJ, Schwartz LB, Irani AM, Awadzi K, Guderian RH, Nutman TB. Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin. J Infect Dis 2002 Nov 1;186(9):1307-13
6682. Doan NM, Keiser PB, Bates RA, Fedorko DP, Weina PJ, Lucey DR. A 33-year-old woman from Nigeria with eosinophilia. Clin Infect Dis 2002 Nov 15;35(10):1204, 1263-4
6683. Duke BO, Marty AM, Peett DL, Gardo J, Pion SD, Kamgno J, Boussinesq M. Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment. Parasitology 2002 Nov;125(Pt 5):431-44
6684. McCarroll L, Hemingway J.Can insecticide resistance status affect parasite transmission in mosquitoes? Insect Biochem Mol Biol 2002 Oct;32(10):1345-51
6685. Roberts L.Mosquitoes and disease. Science 2002 Oct 4;298(5591):82-3
6686. Shriram AN, Murhekar MV, Ramaiah KD, Sehgal SC. Prevalence of diurnally subperiodic bancroftian filariasis among the Nicobarese in Andaman and Nicobar Islands, India: effect of age and gender. Trop Med Int Health 2002 Nov;7(11):949-54
Therapy:
6687. Onwujekwe O, Chima R, Shu E, Okonkwo P. Community-directed treatment with ivermectin in two Nigerian communities: an analysis of first year start-up processes, costs and consequences. Health Policy 2002 Oct;62(1):31-51
6688. Ottesen EA. Major progress toward eliminating lymphatic filariasis. N Engl J Med 2002 Dec 5;347(23):1885-6
6689. Rajendran R, Sunish IP, Mani TR, Munirathinam A, Satyanarayana K. Targeting of children in filariasis mass drug administration. Lancet 2002 Nov 2;360(9343):1430
July 2003
7198.
Ali MM, Baraka OZ, AbdelRahman SI, Sulaiman SM, Williams JF, Homeida MM,
Mackenzie CD. Immune responses directed against microfilariae correlate with
severity of clinical onchodermatitis and treatment history. J Infect Dis
2003 Feb 15;187(4):714-7
7199.
Belizario VY, Amarillo ME, de Leon WU, de los Reyes AE, Bugayong MG,
Macatangay BJ. A comparison of the efficacy of single doses of albendazole,
ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and
Trichuris spp. Bull World Health Organ
2003;81(1):35-42
7200.
Bhunia B, Bhandari YP, Reddy MVR, Harinath BC. Analysis of IgG subclasses
and IgE antibodies across the clinical spectrum of bancroftian filariasis in an
endemic area. Indian J Patho Microbiol 2003; Vol 46(1):113-117.
7201.
Engelbrecht F, Oettl T, Herter U, Link C, Philipp D, Edeghere H, Kaliraj
P, Enwezor F. Analysis of Wuchereria bancrofti infections in a village community
in northern Nigeria: increased prevalence in individuals infected with
Onchocerca volvulus. Parasitol Int
2003 Mar;52(1):13-20
7202.
Rahmah N, Lim BH, Azian H, Ramelah TS, Rohana AR.
Short communication: use of a recombinant antigen-based ELISA to
determine prevalence of brugian filariasis among Malaysian schoolchildren near
Pasir Mas, Kelantan-Thailand border. Trop Med Int Health
2003 Feb;8(2):158-63
7203.
Terhell AJ, Haarbrink M, van den Biggelaar A, Mangali A, Sartono E,
Yazdanbakhsh M. Long-term follow-up of treatment with diethylcarbamazine on
anti-filarial IgG4: dosage, compliance, and differential patterns in adults and
children. Am J Trop Med Hyg
2003 Jan;68(1):33-9
7204.
Zhang X, Ye ZQ, Chen Z, Chen ZQ, Zhu QG, Xin M, Li LC. Comparison of open
surgery versus retroperitoneoscopic approach to chyluria. J Urol
2003 Mar;169(3):991-3
Pathogenesis
7205.
Chadee DD, Rawlins SC, Tiwari TS.
Short communication: concomitant malaria and filariasis infections in
Georgetown, Guyana. Trop Med Int Health. 2003 Feb;8(2):140-3.
7206.
Guevara AG, Vieira JC, Lilley BG, Lopez A, Vieira N, Rumbea J, Collins R,
Katholi CR, Unnasch TR.
Entomological evaluation by pool screen polymerase chain reaction of
Onchocerca volvulus transmission in Ecuador following mass Mectizan
distribution. Am J Trop Med Hyg. 2003 Feb;68(2):222-7.
7207.
Hoerauf A, Buttner DW, Adjei O, Pearlman E.
Onchocerciasis. BMJ. 2003 Jan 25;326(7382):207-10.
7208.
Lobos E, Nutman TB, Hothersall JS, Moncada S.
Elevated immunoglobulin E against recombinant Brugia malayi gamma-glutamyl
transpeptidase in patients with bancroftian filariasis: association with
tropical pulmonary eosinophilia or putative immunity. Infect Immun. 2003
Feb;71(2):747-53.
7209.
Palacio AM, Lichstein DM, Vaamonde CA, Tamariz L.
Parasitic chyluria. South Med J. 2003 Jan;96(1):110-1.
7210.
Rajendran R, Sunish IP, Mani TR.
Mass treatment of filariasis in New Guinea. N Engl J Med. 2003 Mar
20;348(12):1179-81
7211.
Winter AD, Myllyharju J, Page AP.
A hypodermally expressed prolyl 4-hydroxylase from the filarial nematode
Brugia malayi is soluble and active in the absence of protein disulfide
isomerase. J Biol Chem. 2003 Jan 24;278(4):2554-62.
Therapy:
7212.
Addiss DG. Mass
treatment of filariasis in New Guinea. N Engl J Med. 2003 Mar 20;348(12):1179-81
7213.
Babu BV, Satyanarayana K.
Healthcare workers' knowledge of lymphatic filariasis and its control in
an endemic area of Eastern India: implications on control programme. Trop Doct.
2003 Jan;33(1):41-2.
7214.
Burnham G. The
right word. Lancet. 2003 Feb 8;361(9356):456.
7215.
Guevara AG, Vieira JC, Lilley BG, Lopez A, Vieira N, Rumbea J, Collins R,
Katholi CR, Unnasch TR.
Entomological evaluation by pool screen polymerase chain reaction of
Onchocerca volvulus transmission in Ecuador following mass Mectizan
distribution. Am J Trop Med Hyg. 2003 Feb;68(2):222-7.
7216.
Hoerauf A, Buttner DW, Adjei O, Pearlman E.
Onchocerciasis. BMJ. 2003 Jan 25;326(7382):207-10.
7217.
Kerr C. Success
for river blindness control campaign. Lancet Infect Dis. 2003 Feb;3(2):65.
7218.
Nanda B, Krishnamoorthy K.
Treatment seeking behaviour and costs due to acute and chronic forms of
lymphatic filariasis in urban areas in south India. Trop Med Int Health. 2003
Jan;8(1):56-9.
7219. Rajendran R, Sunish IP, Mani TR. Mass treatment of filariasis in New Guinea. N Engl J Med. 2003 Mar 20;348(12):1179-81
October 2003
7938.
De Silva NR, Pathmeswaran A, Fernando SD, Weerasinghe CR, Selvaratnam RR,
Padmasiri EA, Montresor A. Impact of mass chemotherapy for the control of
filariasis on geohelminth infections in Sri Lanka. Ann Trop Med Parasitol. 2003
Jun;97(4):421-5.
7939.
Hoerauf A, Mand S, Volkmann L, Buttner M, Marfo-Debrekyei Y, Taylor M,
Adjei O, Buttner DW. Doxycycline in the treatment of human onchocerciasis:
Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis
in female Onchocerca worms. Microbes Infect. 2003 Apr;5(4):261-73.
7940.
Natarajan R. Another case of human subconjunctival infection by
Macacanema formosana. Arch Ophthalmol. 2003 Apr;121(4):584-5.
7941.
Penzer R. Lymphoedema. Nurs Stand. 2003 May 14-20;17(35):45-51; quiz 52,
55.
7942.
Yoshino N, Hisayoshi T, Sasaki T, Yamauchi S, Oaki Y, Hino M. Human
pulmonary dirofilariasis in a patient whose clinical condition altered during
follow-up. Jpn J Thorac Cardiovasc Surg. 2003 May;51(5):211-3.
Pathogenesis:
7943.
Stanley P, Stein PE. BmSPN2, a serpin secreted by the filarial nematode
Brugia malayi, does not inhibit human neutrophil proteinases but plays a
noninhibitory role. Biochemistry. 2003 May 27;42(20):6241-8.
Therapy:
7944.
Babu BV, Nayak AN.
Footcare among lymphoedema patients attending a filariasis clinic in
South India: a study of knowledge and practice. Ann Trop Med Parasitol. 2003
Apr;97(3):321-4.
7945.
Babu BV, Satyanarayana K.
Factors responsible for coverage and compliance in mass drug
administration during the programme to eliminate lymphatic filariasis in the
East Godavari District, South India. Trop Doct. 2003 Apr;33(2):79-82.
7946.
McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ,
Lammie J, Rheingans R, Lafontant J.
Frequency, severity, and costs of adverse reactions following mass
treatment for lymphatic filariasis using diethylcarbamazine and albendazole in
Leogane, Haiti, 2000. Am J Trop Med Hyg. 2003 May;68(5):568-73.
7947.
Penzer R. Lymphoedema.
Nurs Stand. 2003 May 14-20;17(35):45-51; quiz 52, 55.
7948. Post RJ, Flook PK, Millest AL, Cheke RA, McCall PJ, Wilson MD, Mustapha M, Somiari S, Davies JB, Mank RA, Geenen P, Enyong P, Sima A, Mas J. Cytotaxonomy, morphology and molecular systematics of the Bioko form of Simulium yahense (Diptera: Simuliidae). Bull Entomol Res. 2003 Apr;93(2):145-57.
7949.
Sunish IP, Rajendran R, Mani TR, Gajanana A, Reuben R, Satyanarayana K.
Long-term population migration: an important aspect to be considered
during mass drug administration for elimination of lymphatic filariasis. Trop
Med Int Health. 2003 Apr;8(4):316-21.
7950. Taylor MJ. Wolbachia in the Inflammatory Pathogenesis of Human Filariasis. Ann N Y Acad Sci. 2003 Jun;990:444-449.
7951. Volkmann L, Fischer K, Taylor M, Hoerauf A. Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability.Trop Med Int Health. 2003 May;8(5):392-401.